Canton Biologics

Guangzhou, China
Monoclonal Antibody Bispecific Antibody Recombinant Protein Fusion Protein Plasmid DNA Lentiviral CAR-T AAV
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (2) ○ EMA GMP ○ MHRA GMP

Quick Facts: Canton Biologics

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Guangzhou, China
Modalities
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Fusion Protein, Plasmid DNA, Lentiviral, CAR-T, AAV
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Canton Biologics

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Bispecific Antibody, Recombinant Protein, Fusion Protein, Plasmid DNA, Lentiviral, CAR-T, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press2 articles
Broad modality coverage (8 modalities)

Recent News 2 articles

news Mon, 23 Se
BIOSECURE Act: Pfizer To Lilly - Where Are The Likely Sourcing Gaps? - insights.citeline.com
Source →
news Mon, 20 Ju
After EU withdrawal, catumaxomab ready for phase III trials again under China’s Lintonpharm - BioWorld News
Source →

Frequently Asked Questions About Canton Biologics

What is Canton Biologics's CDMO Signal Score?
Canton Biologics has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Canton Biologics for a manufacturing program?
Use the free AI matchmaker to compare Canton Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Recombinant Protein CDMOs → Plasmid DNA CDMOs → Lentiviral CDMOs → CAR-T CDMOs → AAV CDMOs →

Similar CDMOs

Canton Biologics Co., Ltd.
Foshan (Shunde District), China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Fusion Protein, Plasmid DNA, Lentiviral (process development), Fill-Finish (vial, PFS, lyophilized, BFS)
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 80.6
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein
AsymBio
Shanghai, China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, ADC, Bioconjugates (NDC, RDC, AOC, PDC, BsADC), Plasmid DNA, mRNA, Fill-Finish
Healsun Biopharm (Hangzhou Healsun Biopharm Co., Ltd.)
Hangzhou, China
Monoclonal Antibody, Recombinant Protein, Bispecific Antibody, Fusion Protein, ADC, XDC (ADC, RDC, Bioconjugates), Cell Line Development (CHO)
Chime Biologics
Wuhan, China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Fusion Protein, Biosimilars, ADC (announced/expanding), Drug Product / Fill-Finish